在观察性研究中估计因果效应,用于使用倾向性得分调整的治愈分数的生存数据
Ziwen Wang1, Chenguang Wang2, Xiaoguang Wang1
1School of Mathematical Sciences, Dalian University of Technology, Dalian, Liaoning, China.
Biometrical journal. Biometrische Zeitschrift
|September 6, 2023
概括
这项研究引入了一种新方法,用于在观察性生存数据中估计因果治疗效应,特别是当一些患者未治愈时. 该方法调整了混因素和审查,改善了复杂生存分析中的因果推断.
科学领域:
- 生物统计学 生物统计学
- 流行病学 流行病学
- 因果推理因果推理
背景情况:
- 观察性研究需要对混共变量进行调整,以估计因果治疗效应.
- 对生存数据的审查使因果效应估计变得复杂.
- 一个不可忽视的治愈分数在生存数据分析中带来了额外的挑战.
研究的目的:
- 提出一种新的因果效应估计方法,用于观察性存活率数据与治愈分数.
- 扩展现有的因果效应测量 (受限平均因果效应,SPCE) 以处理生存结果中的治愈分数.
- 开发和验证使用倾向分数分层的因果效应估计器.
主要方法:
- 将绝对治疗效应指标扩展到治疗分数的生存结果.
- 开发基于倾向分数分层的因果效应估计器.
- 证明拟议的估计器的非对称性质,并进行模拟研究.
主要成果:
- 拟议的方法有效地估计了因果治疗效应在存在的混,审查,和治疗分数.
- 模拟研究证明了开发的估计器的性能.
- 这种方法用真实世界胃癌研究来说明.
结论:
- 开发的方法为观察性生存研究中的因果推理提供了一个强大的框架,使用治疗分数.
- 这种方法提高了在复杂的流行病学和临床数据集中准确估计治疗效果的能力.
- 这些发现有助于改善医学研究中的治疗效果估计,特别是在瘤学中.
相关概念视频
Kaplan-Meier Approach
178
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
178
Assumptions of Survival Analysis
153
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
153
Comparing the Survival Analysis of Two or More Groups
222
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
222
Censoring Survival Data
125
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
125
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Introduction To Survival Analysis
276
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
276


